Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $67,010.97 +0.35%
Ethereum $2,056.50 -0.33%
BNB $591.47 +0.86%
Optimism $0.11 +0.61%
Arbitrum $0.09 -1.87%
Solana $80.47 +1.04%
Polygon $0.22 +2.77%
Cosmos $1.70 -1.31%
Avalanche $8.90 -0.14%

Bitcoin $67,010.97 +0.35%
Ethereum $2,056.50 -0.33%
BNB $591.47 +0.86%
Optimism $0.11 +0.61%
Arbitrum $0.09 -1.87%
Solana $80.47 +1.04%
Polygon $0.22 +2.77%
Cosmos $1.70 -1.31%
Avalanche $8.90 -0.14%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B